Infant lymphoblastic leukemia: a single centers 10 year experience

Creative Commons License

Yaman-Bajin I., Aytac Ş. S., Kuskonmaz B. B., Uckan-Cetinkaya D., ÜNAL Ş., GÜMRÜK F., ...Daha Fazla

TURKISH JOURNAL OF PEDIATRICS, cilt.61, sa.3, ss.325-329, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 61 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.24953/turkjped.2019.03.002
  • Dergi Adı: TURKISH JOURNAL OF PEDIATRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.325-329
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Infant acute lymphoblastic leukemia (ALL) is a rare disease and consists of 4-5% of all childhood ALL. Despite improved survival rates in childhood ALL, infants with ALL have a worse prognosis. We aimed to evaluate the clinical features and treatment outcomes of our patients diagnosed with infant ALL at Hacettepe University, Pediatric Hematology Department between 1 January 2008 and 1 January 2018 retrospectively.